Viewing Study NCT02554851


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-02-09 @ 6:20 PM
Study NCT ID: NCT02554851
Status: UNKNOWN
Last Update Posted: 2023-06-15
First Post: 2015-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer.
Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Foot Ulcer, Diabetic View
None Epidermal Growth Factor View
Keywords: